Steatosis News and Research

RSS
Studies provide evidence to clarify role of NAFLD as independent risk factor for development of CVD

Studies provide evidence to clarify role of NAFLD as independent risk factor for development of CVD

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

Metabolic profiling of liver cells suggests new treatments for cirrhosis patients

Metabolic profiling of liver cells suggests new treatments for cirrhosis patients

AP-1 proteins modulate fat accumulation in liver, say researchers

AP-1 proteins modulate fat accumulation in liver, say researchers

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FOXO3 transcription factor may protect against alcohol-induced liver injury

FOXO3 transcription factor may protect against alcohol-induced liver injury

Study: Sugar intake is not directly associated with nonalcoholic fatty liver disease

Study: Sugar intake is not directly associated with nonalcoholic fatty liver disease

Protective effect of estrogen in women with NASH against development of severe fibrosis

Protective effect of estrogen in women with NASH against development of severe fibrosis

Genetic study helps identify obese diabetes patients who are at risk of developing NAFLD

Genetic study helps identify obese diabetes patients who are at risk of developing NAFLD

New study shows that dietary fructose causes liver damage even without weight gain

New study shows that dietary fructose causes liver damage even without weight gain

Study demonstrates accuracy of non-invasive test for NASH diagnosis

Study demonstrates accuracy of non-invasive test for NASH diagnosis

NAFLD is an independent predictor of cardiovascular risk

NAFLD is an independent predictor of cardiovascular risk

Study identifies gene variants associated with histological features of NAFLD

Study identifies gene variants associated with histological features of NAFLD

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

MRI promising for noninvasive hepatic steatosis assessment

MRI promising for noninvasive hepatic steatosis assessment

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

SR9238 compound can reverse effects of fatty liver disease

SR9238 compound can reverse effects of fatty liver disease

Researchers unlock mechanisms of how the body converts dietary carbohydrates into fat

Researchers unlock mechanisms of how the body converts dietary carbohydrates into fat